Avidity Biosciences To Present Preliminary Data From Phase 1/2 FORTITUDETM Trial Of AOC 1020 In People Living With ...
(MENAFN- PR Newswire) Jeffrey M. Statland, M.D., Professor of Neurology, University of Kansas Medical Center, and FORTITUDE trial investigator, will join Avidity management to present data from FORTITUDETM Avidity to host Volume 9 of investor and analyst …